from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Waiver of right of respondents Roche Molecular Systems, Inc.; Roche Diagnostics Corporation; Roche Diagnostics Operations, Inc.; Roche Nimblegen, Inc.; Becton, Dickinson and Company; Becton Dickinson Diagnostics Inc.; and Geneohm Sciences Inc. to respond filed.
Waiver of right of respondents Abbott Laboratories; Abbott Molecular, Inc. to respond filed.
Petition for a writ of certiorari filed. (Response due April 1, 2020)
Application (19A800) granted by The Chief Justice extending the time to file until February 26, 2020.
Application (19A800) to extend the time to file a petition for a writ of certiorari from January 27, 2020 to February 26, 2020, submitted to The Chief Justice.
Enzo Life Sciences, Inc, Petitioner, represented by Justin Patrick Daniel Wilcox
Abbott Laboratories; Abbott Molecular, Inc., Respondent, represented by John Caviness O'Quinn
Roche Molecular Systems, Inc.; Roche Diagnostics Corporation; Roche Diagnostics Operations, Inc.; Roche Nimblegen, Inc.; Becton, Dickinson and Company; Becton Dickinson Diagnostics Inc.; and Geneohm Sciences Inc., Respondent, represented by Thomas Glenn Saunders